KLK3 and pure red-cell aplasia: It is our call that type of health insurance, knowledge about PrCa and PSA, and having had a PSA test in the past, as well as the patient’s characteristics (age, race and family history of PrCa) be considered when discussing with patients the harms/benefits of PSA screening and their preferences to have or not have the PSA test.